Authors: Poon, MC d'Oiron, R Hann, I Negrier, C de Lumley, L Thomas, A Karafoulidou, A Demers, C Street, A Huth-Kuhne, A Petrini, P Fressinaud, E Morfini, M Tengborn, L Marques-Verdier, A Musso, R Devecioglu, O Houston, DS Lethagen, S Van Geet, C von Depka, M Berger, C Beurrier, P Britton, HA Gerrits, W Guthner, C Kuhle, S Lorenzo, JJ Makris, PE Nohe, N Paugy, P Pautard, B Torchet, MF Trillot, N Vicariot, M Wilde, J Winter, M Chambost, H Ingerslev, J Peters, M Strauss, G

Citation: Mc. Poon et al., Use of recombinant factor VIIa (NovoSeven (R)) in patients with Glanzmann thrombasthenia, SEM HEMATOL, 38(4), 2001, pp. 21-25

Authors: Aillaud, MF Morange, P Juhan, I Bauters, A Jude, B Biron-Andreani, C Daures, JP Schved, JF Pernod, G Polac, B Bridey, F De Prost, D Borg, JY Saladin-Theron, C Le Cam, V Denninger, MH Truchaud, F Trossaert, M Boinot, C Sultan, Y Delahousse, B Fimbel, B Gruel, Y Houbouyan, L Bihour, C Vergnes, C Dutrillaux, F Lorenzini, JL Julia, A Deschamps, A Favier, R Freyburger, G Trzeciak, MC Berruyer, M Doumergue, G Gris, JC Toulon, P Montpied, G Marques-Verdier, A Lequerrec, A Guerin, V Massignon, D

Citation: Mf. Aillaud et al., Comparison of thrombotic risk between 85 homozygotes and 481 heterozygotescarriers of the factor V Leiden mutation: retrospective analysis from the Procare Study, BL COAG FIB, 11(6), 2000, pp. 511-518